fakta.uk
Let us introduce ourselves. We are the doctors you trust with your health and the health of your family across every stage of life, from the first checkups in infancy and childhood, to health care during pregnancy and adulthood, through management of chronic illness and aging. We are family physicians, pediatricians, internal medicine physicians, OB-GYNs, […]
How did Novo Nordisk get to the position it’s in now — with its stock halved over the past year and the company widely seen as trailing Eli Lilly in the weight loss market it once led? “I’m not sure I fully accept the premise of the question,” Martin Lange, Novo’s head of development, responded. […]
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. The decision by Health and Human Services Secretary […]
The number of abortions in the U.S. rose again in 2024, with women continuing to find ways to get them despite bans and restrictions in many states, according to a report out Monday. The latest report from the WeCount project of the Society of Family Planning, which supports abortion access, was released a day before the third […]
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on safety and efficacy, further data indicating that CagriSema may not be the standout treatment that investors had hoped for. Novo previously reported that patients on CagriSema lost 20% of their weight in a 68-week Phase […]
CHICAGO — Novo Nordisk’s next-generation obesity injection targeting the amylin hormone showed substantial weight loss in an early study, but similar efficacy across different doses and high rates of side effects raise questions about which dose Novo will pursue going forward. In the Phase 1/2 study testing the drug, called amycretin, patients on the highest […]
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. The ouster of the Food […]
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. This story is an excerpt […]
WASHINGTON — Health and Human Services Secretary Robert F. Kennedy Jr.’s handpicked panel of vaccines advisers will weigh in on two long-approved shots at its first meeting next week, an agenda posted on Wednesday shows. Kennedy recently gutted the panel and appointed eight new members, some of whom have criticized approved vaccines or questioned their […]
Father’s Day without my dad never gets easier. Although he is on my mind every day, I always find myself thinking about him even more often this time of year. My dad was a giant in every sense of the word. More than anyone else, he shaped the values of the Gates Foundation, and everything […]
